22nd Central European Lung Cancer Conference CELCC 2026

26. – 28. 11. 2026  /  Clarion Hotel, Praha

The 22nd Central European Lung Cancer Conference (CELCC) and the 5th Congress on Airway Diagnostics and Interventions (DIDC) are coming together to create a unique multidisciplinary scientific forum. CELCC addresses the full spectrum of lung cancer research and care—from prevention, screening and early diagnosis to the latest advances in translational research and modern treatment strategies.

ABSTRACT SUBMISSION IS CLOSED!

Conference Topics

Up-to date preventive, diagnostic and therapeutic trendsin lung cancer management

On behalf of the Local Organizing Committee, we are pleased to warmly welcome all participants to the 22nd Central European Lung Cancer Conference. Hosting this event in Prague is both an honor and a significant responsibility for our team. Over the years, CELCC has become an important platform for exchanging knowledge and experience across our region, where lung cancer represents a comparable medical, economic, and societal challenge.

The scientific program addresses a broad spectrum of key topics, including basic research, screening, diagnostics, current clinical guidelines, and everyday clinical practice. Distinguished international experts have been invited to share the latest scientific insights across these areas. In addition, the conference features a strong selection of original, high-quality posters and presentations.

Under the auspices of the

CELCA – Central European Lung Cancer Assotiation
VFN – General University Hosital in Prague
ČPFS – Czech Pneumological and Phthiseological Society
ČOS – Czech Society for Oncology
SROBF – Society for Radiation Oncology, Biology and Physics

Scientific committee

Jiří Votruba
Milada Zemanová
Luboš Petruželka, Vice - President CELCA, Prague
Martin Svatoň
Michal Otáhal
Jiří Vachtenheim
Robert Lischke
Robert Pirker, President CELCA, Vienna
Gyula Ostoros, Vice - President CELCA, Budapest
Helmut Prosch
Jan Špaček

International Advisory Committee

AUSTRIA
Martin Filipits, Maximilian Hochmair, Thorsten Fureder

CROATIA
Marko Jakopovic

CZECH REPUBLIC
Jana Skřičková, Aleš Ryška, Vladimír Koblížek, Pavel Dundr

GERMANY
Wilfried Eberhardt, Rudolf M. Huber

HUNGARY
Krisztina Bogos, Gabriella Gálffy, Judit Moldvay, Zsolt Pápai Székely

POLAND
Rafal Dziadziuszko, Joanna Chorostowska, Jacek Niklinski

SERBIA
Nevena Secen, Bojan Zaric, Dragana Jovanovic

SLOVAKIA

Peter Berzinec, Michal Urda, Gabriela, Chowaniecová, Milada Veselá, 

 

SLOVENIA

Kovac Viljem, Mirjana Rajer

Program topics

PNEUMO-ONCOLOGY

Early detection & screening – Pros & cons

Tobacco control

Smoking cessation

Impact of artificial intelligence for diagnosis of lung cancer

Multimodality therapy of operable NSCLC

Management of locally advanced NSCLC

Metastatic NSCLC

SCLC

MDT-based care of lung cancer

Best of pneumo-oncology 2026

    PULMONOLOGY

    Imaging & Navigation – Pros & Cons

    • CT-guided vs bronchoscopic approach
    • Cone-beam CT: benefit vs radiation exposure
    • Robotic navigation – reality vs hype

    Tissue Acquisition

    • Peripheral lesion biopsy techniques
    • Cryobiopsy vs conventional tools
    • Complications and management

    From Biopsy to Biomarker

    • Sample quality
    • Common failures
    • Role of liquid biopsy

    Interdisciplinary Case Arena

    • Solitary pulmonary nodules
    • Borderline operability
    • Strategy failures

    PARTNERS

    GOLD

    SILVER

    BRONZE

    PARTNERS

    Hosted by

    Czech Lung Cancer Cooperative Group
    CELCA – Central European Lung Cancer Association

    Conference Office

    EDUCARE SOLUTION / VIZOO IMAGE PRODUCTION, Jáchymova 3, 110 00 Praha 1, Czech Republic

    IČO: 04392370, DIČ: CZ04392370
    Mgr. Zuzana Poláčková, Mgr. Peter Vanek
    E-mail: info@plicnikongres.cz

    Conference venue

    Clarion Congress Hotel Prague, Freyova 33, 190 00 Praha 9